What Changed
Price Move History
- Daily moves over 5%
- 7 38 sessions, September 30, 2025 to October 12, 2026
- Largest daily move
- +400% close of January 22, 2026
- 1-year change
- -66.7% closing prices, September 30, 2025 to October 12, 2026
- 1-month change
- -50% closing prices, September 11, 2026 to October 12, 2026
Company Description
NOVACCESS GLOBAL (OTC: XSNX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $6.2K.
XSNX has declined 66.7% over the past year. The last closing price was $0.0001.
For FY2024, NOVACCESS GLOBAL reported revenue of $0 and diluted earnings per share of -$0.06.
This page collects what Stock Titan holds for XSNX, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
NOVACCESS GLOBAL (XSNX) closed at $0.0001 on October 12, 2026. Over the past 12 months, the price has lost 66.7%.
XSNX Metrics & Rankings
Price returns through October 12, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NOVACCESS GLOBAL has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, management, partnership, AI. View all XSNX news →
SEC Filings
NOVACCESS GLOBAL has filed 1 recent SEC filing, including 1 Form 10-K. The most recent filing was submitted on January 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all XSNX SEC filings →
Financial Highlights
Diluted earnings per share stood at -$0.06. The company generated -$215K in operating cash flow. The current ratio was 0.01, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in NOVACCESS GLOBAL (XSNX) currently stands at 439 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for NOVACCESS GLOBAL (XSNX) currently stands at 219.5 days, up 21850% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 400%. Across the settlements charted above, it has ranged from 1.0 to 219.5 days.
XSNX Company Profile & Sector Positioning
NOVACCESS GLOBAL (XSNX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing XSNX often look at related companies in the same sector, including BETTER THERAPEUTICS INC (BTTX), STATERA BIOPHARMA INC (STAB), RENOVACARE INC (RCAR), COMERA LIFE SCIENCES HLDG (CMRA), and VIRPAX PHARMS INC (VRPX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate XSNX's relative position within its industry.